Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro chemo-protective effect of bioactive peptide lunasin against oxidative stress in human HepG2 cells

  • Fernández-Tomé, Samuel
  • Ramos, Sonia
  • Cordero Herrera, Isabel
  • Recio, Isidra
  • Goya, Luis
  • Hernández-Ledesma, Blanca
Lunasin is a peptide with proven properties against cancer and cardiovascular diseases. Relevant amounts of lunasin have been found in liver of rats fed lunasin-enriched diets, indicating its potential bioactive effect in this tissue. This study investigated the stability of lunasin in human liver HepG2 cells, and its chemoprotective effect against oxidative stress induced by tert-butylhydroperoxide. Pre-treatment of cells with lunasin (0.5-10. μM) significantly prevented the increased reactive oxygen species (ROS) generation (122% compared to 190% in stressed cells), and glutathione peroxidase and catalase activities, as well as the depletion of reduced glutathione. By restraining ROS overproduction, lunasin evoked a decline in carbonyl groups, and a significant recovery from cell death by apoptosis. These findings suggest that lunasin, at physiological concentrations, might confer a significant chemoprotective effect against oxidative stress-associated liver disorders. In addition, fragments released after hydrolysis of lunasin by cell enzymes might contribute to the observed antioxidant effects., This work was supported by projects AGL2010-17579, AGL2011-24643, and CSD2007-00063 from Programa Consolider-Ingenio from the Spanish Ministry of Education and Science (CICYT), FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), and FP7-SME-2012-315349, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cells

  • García-Nebot, María José
  • Recio, Isidra
  • Hernández-Ledesma, Blanca
Oxidative stress is one of the most critical factors implicated in many disorders of the gastrointestinal tract, such as inflammatory bowel diseases and colon cancer. Lunasin is a seed peptide known by its properties against cancer and cardiovascular diseases. The present study investigated the in vitro antioxidant activity of this peptide that demonstrated to be a potent scavenger of peroxyl and superoxide radicals. In addition, the protective role of lunasin on cell viability and antioxidant defenses of human Caco-2 cells challenged by hydrogen peroxide and tert-butylhydroperoxide was evaluated. This peptide remained partially intact during incubation time with cells, preventing of the oxidative damage induced by both chemical agents. The direct antioxidant action of lunasin (within the physiological range of concentrations) on enterocytes exposed to oxidizing species makes this peptide a promising agent to preserve the integrity of intestinal mucosa against oxidative damage related diseases. © 2013 Elsevier Ltd., This work has received financial support from projects AGL2011-24643, Consolider Ingenio 2010 FUN-C-Food CSD2007-00063, P2009/AGR-1469, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN) and FP7-SME-2012-315349 (FOFIND). The authors are participant in the FA1005COST Action INFOGEST on food digestion. B.H.-L. acknowledges Ministry of Economy and Competitiveness for her “Ramón y Cajal” contract., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dairy protein hydrolysates: Peptides for health benefits

  • Hernández-Ledesma, Blanca
  • García-Nebot, María José
  • Fernández-Tomé, Samuel
  • Amigo, Lourdes
  • Recio, Isidra
Trabajo presentado a la 8th NIZO Dairy Conference celebrada del 11 al 13 de septiembre de 2013 en Arnhem (Holanda)., During food digestion, proteins are hydrolysed into a large variety of peptides. Some of these peptides are structurally similar to sequences acting in the organism as endogenous signals, or hormones. Therefore, homologous food peptides can interact with the same receptors or enzymes in the organism, and in this form, exert an agonistic or antagonistic activity. The evidence of the potential of these dietary peptides to modulate numerous physiological conditions has been mainly achieved using in vitro assays; however, it is accepted that health evidence has to be based on in vivo trials (animals or humans) since the activity of these molecules depends on the ability of these peptides to reach the target tissue in an active form, which in turn depends on their structure. This article reviews the literature on the physiological effects of milk-derived bioactive peptides with special emphasis in the evidence achieved in animal and human trials., This work has received financial support from projects AGL2011-24643, Consolider Ingenio 2010 FUN-C-Food CSD2007-00063, PIE 201270E076, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), and FP7-SME-2012-315349 (FOFIND). The authors are participant in the FA1005COST Action INFOGEST on food digestion. B. H. -L. and S. F. -T. acknowledge CSIC and the Ministry of Economy and Competitiveness for their Ramón y Cajal contract and FPI fellowship, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats

  • Sánchez-Rivera, Laura
  • Ares, Irma
  • Miralles, Beatriz
  • Gómez-Ruiz, José Ángel
  • Recio, Isidra
  • Martínez-Larrañaga, M. R.
  • Anadón, Arturo
  • Martínez, Maria A.
The aim of this study was to investigate the oral bioavailability and kinetics of the milk casein-derived peptide HLPLP, which had previously demonstrated antihypertensive effect in spontaneously hypertensive rats. HLPLP disposition after single intravenous (4 mg/kg body weight) and oral (40 mg/kg body weight) doses was studied in rats. Plasma concentrations of HLPLP [β-casein fragment f(134-138)], and two derived fragments found after HLPLP administration, LPLP [β-casein fragment f(135-138)] and HLPL [β-casein fragment f(134-137)], were determined by ultrahigh performance liquid chromatography (UPLC) coupled on line to a Q-TOF instrument. For HLPLP, the elimination half-lives (T1/2β) were 7.95 min after intravenous and 11.7 min after oral administration. The volume of distribution at steady state (Vss = 30.8 L/kg) suggests a considerable uptake of HLPLP into tissues. HLPLP was converted to the peptides LPLP and HLPL. After HLPLP intravenous administration, the elimination half-lives (T1/2β) for these biotransformed peptides, LPLP and HLPL, were 8.38 and 10.9 min, respectively. After oral administration, HLPLP was rapidly absorbed with an absorption half-life (T1/2a) of 2.79 min. The oral bioavailability of HLPLP was found to be 5.18%. Our study suggested that HLPLP was rapidly absorbed and eliminated after oral administration, biotransformed into smaller fragments LPLP and HLPL, and distributed throughout the body by the circulation blood. The present pharmacokinetic information from a preclinical kinetic study in rats can also play an important role in designing future kinetic studies in humans for assessing HLPLP dose-response relationship., This work was supported by projects Consolider-Ingenio FUNC-Food CSD 2007-063, FP7-SME-2012-315349 (FOFIND), and AGL2011-24643 from Ministerio de Economiá y Competitividad, projects P2009/AGR-1469 and (ALIBIRDCM) S2013/ABI-2728 from Comunidad de Madrid, and project 920204 UCM-BSCH from Universidad Complutense de Madrid., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Peptidomics for discovery, bioavailability and monitoring of dairy bioactive peptides

  • Sánchez-Rivera, Laura
  • Martínez-Maqueda, D.
  • Cruz-Huerta, Elvia
  • Miralles, Beatriz
  • Recio, Isidra
Trabajo presentado al 3rd Foodomics Conference: Foodomics a new comprehensive approach to food and nutrition., In the last years, the identification and characterization of bioactive peptides have become emerging research subjects. Food peptidomics can be considered a subfield of the food proteomics focused on composition, interaction and properties of peptides present in a food matrix. On the basis of the description of recent works, the objective of this review is to highlight the increasing role of peptidomics as indispensable tool in the fields of discovery, bioavailability and monitoring of dairy bioactive peptides. The enhanced peptide identification, resulting from the valuable mass spectrometry development and the regular use of high-resolution techniques, supports the application of peptidomic approaches in the case of empirical bioactive peptide identification workflow. Bioinformatic-driven approaches have gradually gained importance through the wider application of in silico analysis, structure activity relationship models, chemometrics and peptide database management. Investigations of bioactive peptide modifications during digestion, whether it be selective or untargeted search using peptidomic tools have been discussed, as well as peptide changes along absorption, distribution, metabolism and elimination, including studies in cellular and animal models. Examples of application of peptidomics in the analysis of bioactive peptide occurrence in dairy products together with peptide monitoring during scaling up, industrial treatments and storage have been also described., This work has received financial support from projects AGL2011-24643, Consolider IngenioCSD2007-00063, P2009/AGR-1469, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), Intramural201270E076 and FP7-SME-2012-315349 (FOFIND). The authors are participant in the FA1005COST Action INFOGEST on food digestion. L.S.-R. acknowledges CSIC for the JAE Program fellowship (BOE 29-01-10). E. C-H. thanks the scholarship PROMEP/103.5/13/6408 for the support for PhD studies abroad., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Caseinophosphopeptides released after tryptic hydrolysis versus simulated gastrointestinal digestion of a casein-derived by-product

  • Cruz-Huerta, Elvia
  • García-Nebot, María José
  • Miralles, Beatriz
  • Recio, Isidra
  • Amigo, Lourdes
The production of caseinophosphopeptides from a casein-derived by-product generated during the manufacture of a functional ingredient based on antihypertensive peptides was attempted. The casein by-product was submitted to tryptic hydrolysis for 30, 60 and 120 min and further precipitated with calcium chloride and ethanol at pH 4.0, 6.0 and 8.0. Identification and semi quantification of the derived products by tandem mass spectrometry revealed some qualitative and quantitative changes in the released caseinophosphopeptides over time at the different precipitation pHs. The by-product was also subjected to simulated gastrointestinal digestion. Comparison of the resulting peptides showed large sequence homology in the phosphopeptides released by tryptic hydrolysis and simulated gastrointestinal digestion. Some regions, specifically αS1-CN 43-59, αS1-CN 60-74, β-CN 1-25 and β-CN 30-50 showed resistance to both tryptic hydrolysis and simulated digestion. The results of the present study suggest that this casein-derived by-product can be used as a source of CPPs. © 2014 Elsevier Ltd. All rights reserved., This work has received financial support from projects AGL2011-24643, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN) and FP7-SME-2012-315349 (FOFIND). The authors are participants in the FA1005 COST Action INFOGEST on food digestion. E. C.-H. thanks the University of Veracruz, México, scholarship PROMEP/103.5/13/6408 for the support for PhD studies abroad., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Comparison of hydrolysis time and precipitation pH in the production of caseinophosphopeptides from a casein by-product

  • Cruz-Huerta, Elvia
  • García-Nebot, María José
  • Miralles, Beatriz
  • Recio, Isidra
  • Amigo, Lourdes
Póster presentado a la 3rd Internacional Conference on Food Digestion celebrada en Wageningen (Holanda) del 11 al 13 de marzo de 2014., The production of caseinophosphopeptides (CPPs) from a casein-derived by-product generated during the manufacture of an antihypertensive hydrolysate was attempted. CPPs are phosphorylated bioactive peptides that can be released from casein by enzymatic digestion. Due to the phosphorylated serines, these peptides are relatively resistant to be further hydrolysed and it has been proposed that they could prevent the precipitation of metal ions at alkaline pH in the distal small intestine. In order to isolate CPPs from the casein fraction of milk, an enzymatic hydrolysis process is often followed by selective precipitation with calcium chloride and ethanol using pHs in the range 3.5 to 8.5. It has been reported that at pH 3.5 only peptides containing the phosphorylated cluster sequence SerP-SerP-SerP-Glu-Glu selectively precipitate from a tryptic digest of casein. However, at higher pH an increase of the recoveries of the di- and monophosphorylated peptides was observed. The objective was to investigate if the hydrolysis time and pH used for the selective precipitation could determine the characteristics of the products recovered using tandem mass spectrometry for peptide sequencing. The casein by-product was submitted to tryptic hydrolysis during 30, 60, and 120 min and further precipitated with calcium chloride and ethanol at pH 4.0, 6.0 and 8.0. The results show the low influence of the hydrolysis time and suggest that precipitation at pH 6 and 8 permit to recover a valuable CPPs fraction and use this casein-derived by-product as source of CPPs. Identification of CPPs in the samples of CN-derived by-product after being subjected to simulated gastrointestinal digestion showed that this process generates CPP sequences very similar to those produced by tryptic hydrolysis. These results suggest that this CN-derived by-product can be used as a source for CPPs after its passage through the gastrointestinal tract opening the door for its use as functional ingredient to improve mineral bioavailability., This work has received financial support from projects AGL2011-24643, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), and FP7-SME-2012-315349 (FOFIND). The authors are participants in the FA1005 COSt Action INFOGEST on food digestion. E. C-H. thanks, scholarship PROMEP/103.5/13/6408 for the support for PhD studies abroad., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Peptidos bioactivos derivados de proteínas alimentarias con actividades beneficiosas para la salud

  • Amigo, Lourdes
  • Hernández-Ledesma, Blanca
  • Miralles, Beatriz
  • Miralles, Beatriz
  • Martínez-Maqueda, D.
  • Sánchez-Rivera, Laura
  • Cruz-Huerta, Elvia
  • Fernández-Tomé, Samuel
  • Miguel, Marta
  • Garcés-Rimón, Marta
  • Recio, Isidra
Resumen del trabajo presentado a las I Jornadas Científicas del CIAL celebradas el 5 de junio de 2014 en Madrid., Una de las principales líneas de investigación del grupo BIOPEP se enfoca en el papel beneficioso para la salud ejercido por proteínas y péptidos de origen alimentario. Los trabajos están dirigidos al desarrollo de nuevos ingredientes alimentarios con funcionalidad biológica mediante procesos enzimáticos o fermentativos y su caracterización química y bioquímica mediante técnicas clásicas o de proteómica. Además, se llevan a cabo estudios de evaluación de la actividad biológica en cultivos celulares, modelos animales o estudios de intervención en humanos. Las propiedades fisiológicas que actualmente centran el interés del grupo incluyen la actividad antihipertensiva, los efectos protectores a nivel gastro-intestinal y sobre el estrés oxidativo, la actividad frente a la diabetes y el síndrome metabólico, los efectos anti-cancerígenos y la actividad moduladora del transporte y la absorción mineral. Otros aspectos como el mecanismo de acción, la relación estructura-actividad, la biodisponibilidad y farmacocinética de los péptidos bioactivos, así como los beneficios y riesgos que comportan para la salud humana también son objeto de estudio. El grupo cuenta con expertos en técnicas electroforéticas, cromatográficas, espectrometría de masas, cultivos celulares, modelos animales y expresión génica., Los autores agradecen la financiación otorgada por el Ministerio de Economía y Competitividad a través de los proyectos AGL2011-24643 y AGL2012-32387, por la Unión Europea a través del proyecto FP7-SME-2012-315349 (FOFIND) y por la Comunidad de Galicia a traves de los proyectos FEDER-INNTERCONECTA-GALICIA ENVELLEFUN y LACTMETABOL. Los miembros del grupo son participantes en la Acción Europea FA1005COST INFOGEST sobre digestión de alimentos., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Lunasina, un péptido alimentario biodisponible, ejerce efectos protectores frente al estrés oxidativo en células hepáticas humanas

  • Fernández-Tomé, Samuel
  • Ramos, Sonia
  • Cordero Herrera, Isabel
  • Recio, Isidra
  • Goya, Luis
  • Hernández-Ledesma, Blanca
Póster presentado en las I Jornadas Científicas CIAL Forum 2014, celebrado en Madrid el 5 de junio de 2014., Lunasina es un péptido con propiedades frente al cáncer y los trastornos cardiovasculares. Es protegido de la acción de enzimas gástricas y pancreáticas por inhibidores de proteasas naturalmente presentes en las plantas. Estudios de biodisponibilidad en animales y humanos han demostrado que un elevado porcentaje del péptido ingerido permanece intacto durante su paso por el tránsito gastrointestinal, alcanzando los órganos diana en una forma intacta y activa. El daño celular causado por las especies reactivas de oxígeno (ROS) juega un papel crucial en la inducción y progresión de diversos trastornos a nivel hepático. Hay un interés creciente en la búsqueda de nuevos compuestos protectores hepáticos frente al daño oxidativo, siendo los antioxidantes de origen natural una de las alternativas más prometedoras. Los objetivos del estudio fueron evaluar la estabilidad de la lunasina en células humanas HepG2 como modelo de hepatocitos, e investigar su potencial quimiopreventivo frente al daño oxidativo inducido por el agente oxidante, tert-butil hidroperóxido. El pre-tratamiento de las células con lunasina provocó una significativa reducción de la generación de ROS y de las actividades de la glutatión peroxidasa y la catalasa, así como la restauración de los niveles reducidos de glutatión. Además, el péptido evitó el efecto sobre los grupos carbonilo y permitió la recuperación de la célula frente a la apoptosis inducida por el agente químico. Los estudios de estabilidad sugieren, que además del péptido remanente, los cinco fragmentos liberados tras su hidrólisis podrían ser los responsables de los efectos protectores observados en el estudio., Este trabajo ha sido financiado por los proyectos AGL2010-17579, AGL2011-24643, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), y FP7-SME-2012-315349. I. C. -H. y S. F. -T. agradecen al MINECO sus becas FPI, y B. H. -L. su contrato post-doctoral “Ramón y Cajal”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel peptides derived from αs1-casein with opioid activity and mucin stimulatory effect on HT29-MTX cells

  • Fernández-Tomé, Samuel
  • Martínez-Maqueda, D.
  • Girón, Rocío
  • Goicoechea, Carlos
  • Miralles, Beatriz
  • Recio, Isidra
The opioid effect of α-casein fragments related to AYFYPEL and YFYPEL, which had previously shown mucin-stimulatory activity in human goblet cells, was investigated. Peptides YFYPEL and YFYPE showed opioid agonistic activity in guinea pig ileum, and in mouse vas deferens but to a lower extent. Peptides were partly hydrolysed during the assay and several of the resulting fragments lost the N-terminal Tyr residue. Docking of peptides YFYPEL (active) and YFYP (inactive) into the active site of the opioid receptor model showed remarkable differences regarding the flexibility at the third intracellular loop of the receptor and the interaction with Pro at the peptide C-terminus that forced residues Arg and Glu from the receptor to move towards the interior of the binding pocket. The study on human cells HT29-MTX has shown that YFYPEL is the minimum fragment able to stimulate MUC5AC expression., This work has received financial support from projects AGL2015-66886-R from the Spanish Ministry of Economy and Competitiveness (MINECO), SAF2012-40075-C02-01 from the Spanish Ministry of Science and Innovation (MICINN), and FP7-SME-2012-315349 (FOFIND) financed by the European Commission (EC). S. F.-T. acknowledges MINECO for his FPI fellowship., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Short communication: Identification of iron-binding peptides from whey protein hydrolysates using iron (III)-immobilized metal ion affinity chromatographyand reversed phase-HPLC-tandem mass spectrometry

  • Cruz-Huerta, Elvia
  • Martínez-Maqueda, D.
  • Hoz, Lucia de la
  • Nunes da Silva, Vera S.
  • Bertoldo Pacheco, Maria Teresa
  • Amigo, Lourdes
  • Recio, Isidra
Peptides with iron-binding capacity obtained by hydrolysis of whey protein with Alcalase (Novozymes, Araucaria, PR, Brazil), pancreatin, and Flavourzyme (Novozymes) were identified. Hydrolysates were subjected to iron (III)-immobilized metal ion affinity chromatography, and the bound peptides were sequenced by mass spectrometry. Regardless of the enzyme used, the domains f(42-59) and f(125-137) from β-lactoglobulin enclosed most of identified peptides. This trend was less pronounced in the case of peptides derived from α-lactalbumin, with sequences deriving from diverse regions. Iron-bound peptides exhibited common structural characteristics, such as an abundance of Asp, Glu, and Pro, as revealed by mass spectrometry and AA analysis. In conclusion, this characterization of iron-binding peptides helps clarify the relationship between peptide structure and iron-chelating activity and supports the promising role of whey protein hydrolysates as functional ingredients in iron supplementation treatments., This work received financial support from projects AGL2011-24643 from the Ministerio de Economía y Competitividad of Spain; CONETA-PEME IN852A 2013/39-0 from Xunta de Galicia of Spain; FP7-SME-2012-315349 (FOFIND) from the European Union; Fundaçao de Amparo a Pesquisa de Sao Paulo, Brazil; and IBEROFUN 110AC0386 from Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo. E. C.-H. thanks the Universidad Veracruzana and the Program for the Improvement of Teaching (PROMEP) of México for awarding the scholarship for supporting PhD studies abroad., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Peptide fragments from β-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity

  • Sánchez-Rivera, Laura
  • Ferreira Santos, Pedro
  • Miralles, Beatriz
  • Carrón, Rosalía
  • Montero, Mª José
  • Recio, Isidra
The intact absorption of a β-casein peptide, HLPLP, into rat blood circulation after oral administration was recently demonstrated. In addition to the parent peptide, several derived fragments were detected in rat plasma. The aim of the present work is to elucidate whether these fragments retain antihypertensive activity and if their activity is mediated by angiotensin-converting-enzyme inhibition. The penta-peptide was incubated in rat plasma in order to identify and quantify the fragments generated by the action of plasmatic peptidases on HLPLP, using tandem mass spectrometry. Peptides HLPL, LPLP and HLP were generated within seconds of incubation. The parent peptide, HLPLP, and all possible derived peptides showed potent antihypertensive activity in spontaneously hypertensive rats and caused inhibition of vascular contraction elicited by angiotensin-I. It can be concluded that the antihypertensive effect of HLPLP can be produced by the concomitant action of the parent peptide and several novel derived fragments., This work was supported by projects AGL2011-24643 from the Spanish Ministry of Economy and Competitiveness, and FP7-SME-2012-315349 (FOFIND). The authors are participants in the FA1005 COST Action INFOGEST on food digestion. Laura Sanchez-Rivera wants to acknowledge CSIC for a JAE Program fellowship., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effects of milk casein hydrolyzate supplemented with phytosterols on hypertension and lipid profile in hypercholesterolemic hypertensive rats

  • Ferreira Santos, Pedro
  • Carrón, Rosalía
  • Recio, Isidra
  • Sevilla, Mª Ángeles
  • Montero, Mª José
This study investigates the beneficial effect of a milk casein hydrolyzate supplemented with phytosterols in hypercholesterolemic hypertensive rats. Spontaneously hypertensive rats were fed for 8 weeks with standard diet, or high cholesterol diet alone and supplemented with casein hydrolyzate or casein hydrolyzate plus phytosterols. Blood pressure was measured by tail-cuff method, vascular reactivity was performed on isolated aorta and biochemical parameters were evaluated in plasma. The hypercholesterolemic diet caused elevation of total cholesterol, low-density lipoprotein cholesterol, atherogenic index, lipid peroxidation, liver size and hepatic steatosis accompanied with a severe reduction of high-density lipoprotein cholesterol. The treatment with the casein hydrolyzate reduced blood pressure, cardiac hypertrophy and oxidative stress, and improved the endothelial function. The incorporation of phytosterols prevented the changes caused by the hypercholesterolemic diet and increased the antioxidant effect of casein hydrolyzate. In conclusion, treatment with milk casein hydrolyzate supplemented with phytosterols provides benefits when coexisting hypertension and hypercholesterolemia., This work was supported by project FP7-SME-2012-315349 (FOFIND) financed by the European Commission. Pedro Ferreira Santos was the recipient of a fellowship funded from this project., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

HT29 Cell Line

  • Martínez-Maqueda, D.
  • Miralles, Beatriz
  • Recio, Isidra
This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License., The human colon adenocarcinoma cell line HT29, is not only used to study the biology of human colon cancers, but it is receiving special interest in studies focused on food digestion and bioavailability due to the ability to express characteristics of mature intestinal cells. In the differentiated phenotype, they are able to form a monolayer with tight junctions between cells and a typical apical brush border. In addition, these differentiated cells express brush-border-associated hydrolases typical of the small intestine although the enzymatic activity is lower than that found in vivo. Although they represent a valuable model due to their similarities with enterocytes of the small intestine, their limitations and the relevance to the in vivo situation are also considered in this chapter. The application of this cell line to transport studies of drugs and food compounds is illustrated, especially when the effect of the mucus layer is considered or used as co-culture in combination with Caco-2 cells. They have also been frequently used to study the intestinal immune response to bacterial infection, and microorganism survival, adhesion or invasion. Finally, the use of these cells to evaluate the effect of several food compounds and mucin secretion is summarized., This work was supported by projects AGL2011-24643 from Ministerio de Economía y Competitividad and FP7-SME-2012-315349 (FOFIND). The authors are participants in the FA1005 COST Action INFOGEST on food digestion., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antiulcerative activity of milk proteins hydrolysates

  • Carrillo, W.
  • Monteiro, Karin M.
  • Martínez-Maqueda, D.
  • Ramos González, María Mercedes
  • Recio, Isidra
  • Carvalho, João Ernesto de
Several studies have shown the protective effect of dairy products, especially α-lactalbumin and derived hydrolysates, against induced gastric ulcerative lesions. The mucus strengthening represents an important mechanism in the defense of gastrointestinal mucosa. Previously, a hydrolysate from casein (CNH) and a hydrolysate from whey protein concentrate rich in β-lactoglobulin (WPH) demonstrated a stimulatory activity on mucus production in intestinal goblet cells. The aim of this work was to evaluate the possible antiulcerative activity of these two hydrolysates in an ethanol-induced ulcer model in rats. All tested samples significantly reduced the ulcerative lesions index (ULI), compared with the saline solution, using doses of 300 and 1000 mg kg body weight with decreases up to 66.3% ULI. A dose-response relationship was found for both hydrolysates. The involvement of endogenous sulfhydryl (SH) groups and prostaglandins (PGs) in the antiulcerative activity was evaluated using their blockage. The antiulcerative activity of WPH showed a drastic decrease in presence of N-ethylmaleimide (from 41.4% to 9.2% ULI). However, the CNH antiulcerative properties were not significantly affected. The cytoprotective effect of WPH appears to depend on a PG-mediated mechanism. In conclusion, CNH and WPH demonstrated in vivo antiulcerative properties and represent a promising alternative as protectors of the gastric mucosa., This work has received financial support from the projects CYTED110AC0386 (IBEROFUN), AGL2011-24643, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), FP7-SME-2012-315349 (FOFIND), and CNPq (Brasil)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antiulcerative and antinociceptive activities of casein and whey proteins

  • Carrillo, W.
  • Monteiro, Karin M.
  • Spindola, Humberto
  • Ramos González, María Mercedes
  • Carvalho, João Ernesto de
The aim of this study was to evaluate the antiulcerative and antinociceptive activities of milk proteins using the induced gastric ulcer with ethanol rat model and the acetic acid-induced writhing mouse model. Casein (CN), (100, 300, and 1000 mg kg) doses presented antiulcerative activity on a dose-dependent manner with values of 30.8%, 41.4%, and 57.0% of inhibition measured using the ulcerative lesions index (ULI), respectively. Whey protein concentrate (WPC), (100, 300, and 1000 mg kg) doses presented antiulcerative activity on a dose-dependent manner with values of 48.9%, 65.5%, and 68.22% of ULI inhibition, respectively. CN, casein hydrolysates (CNH), WPC, and whey protein hydrolysates (WPH), (3, 10, and 30 mg kg) doses presented antinociceptive activity using the acetic acid-induced writhing in the mouse model. CN (30 mg kg) presented a value of 40% of inhibition writhing, and CNH (30 mg kg) presented antinociceptive activity with a value up to 46% of writhing inhibition. WPC (30 mg kg) presented a value of 52.50%, and WPH (30 mg kg) presented antinociceptive activity with a value up to 88.00% of writhing inhibition. In conclusion, CN and WPC demonstrated in vivo antiulcerative properties and represent a promising alternative to be used as protectors of the gastric mucosa. CNH and WPH demonstrated in vivo antiulcerative properties and represent a promising alternative to be used as natural analgesic., This work has received financial support from the projects CYTED110AC0386 (IBEROFUN), AGL2011-24643, FEDER-INNTERCONECTA-GALICIA (ENVELLEFUN), FP7-SME-2012-315349 (FOFIND), and CNPq (Brazil)., Peer Reviewed